• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number 10371
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Transient Ischemic Attack (2109)
Date of Event 10/21/2022
Type of Reportable Event Serious Injury
Event or Problem Description
Asap too study.It was reported that the patient experienced a transient ischemic attack.Prior to the procedure, the patient was on aspirin and clopidogrel.A left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) and a 33mm watchman laa closure device & delivery system (wds) were selected to be used.The procedure was successfully completed with the closure device implanted in the laa of the patient with a complete seal and a deployed device diameter of 28.2 mm.Post implant procedure clopidogrel was continued.Five (5) years post procedure the patient presented to the hospital with perioral numbness, slight right sided facial droop, and worsening of right arm weakness.The patient at the time was not on any anticoagulation medication.On the same day, a computed tomography (ct) head, ct head/neck were negative.Additionally, a chest x-ray was also performed.The following day, magnetic resonance imaging (mri) was performed, and it was negative.The patient was diagnosed with a transient ischemic attack.The patient was put on 81mg aspirin and 40mg atorvastatin in response to this event.Two days after presenting to the hospital the event was resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15700280
Report Number2124215-2022-44294
Device Sequence Number6352842
Product Code NGV
UDI-Device Identifier08714729838265
UDI-Public08714729838265
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 10/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2019
Device Model Number10371
Device Catalogue Number10371
Device Lot Number0019786104
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/26/2022
Initial Report FDA Received Date10/31/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/30/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age76 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-